Methylene Chloride

Methylene Chloride

SCHEMBL6847437

COC(=O)CNC(=O)c1ccc(-c2ccccc2)cc1.ClCCl

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.62
MAPT P10636 2/20 0.62
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
MAPK1 P28482 1/20 0.59
SMN1; SMN2 Q16637 7/20 0.56
HPGD P15428 2/20 0.56
POLB P06746 1/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
TP53 P04637 1/20 0.56
NPC1 O15118 2/20 0.55
HTT P42858 1/20 0.55
KDM4E B2RXH2 2/20 0.51
TSHR P16473 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TRPV1 Q8NER1 1/20 0.51
HIF1A Q16665 1/20 0.50
EPHX2 P34913 1/20 0.50
NR1H4 Q96RI1 1/20 0.50
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5632141 0.95 RAB9A (0.67) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL3961994 0.85 GAA (0.59) RAB9AMAPTMEN1KMT2AMAPK1
Hydrochloric Acid SCHEMBL9331679 0.84 GAA (0.57) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL8947242 0.83 KMT2A (0.67) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL29035299 0.83 LMNA (0.55) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL71818 0.82 RAB9A (0.66) RAB9AMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL26568778 0.82 MAPK1 (0.80) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL26568178 0.81 KMT2A (0.59) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL24224262 0.80 KMT2A (0.59) RAB9AMAPTMEN1KMT2AMAPK1
SCHEMBL30838576 0.80 KDM4E (0.62) RAB9AMAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389211-A1 3,7-DIAZYBICYCLO 3.3.1] FORMULATIONS AS ANTIARRHYTMIC COMPOUNDS AstraZeneca AB (SE) 2004-02-18 EP disclosed
WO-2002083687-A1 3,7-DIAZYBICYCLO [3.3.1] FORMULATIONS AS ANTIARRHYTMIC COMPOUNDS ASTRAZENECA AB (SE) 2002-10-24 WO disclosed